These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 28163909)

  • 41. Is NSAID use in children associated with the risk of renal injury?
    Kirpalani A; Rieder M
    Paediatr Child Health; 2019 May; 24(2):119-121. PubMed ID: 30996603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute kidney injury: definition, diagnosis and epidemiology.
    Rossaint J; Zarbock A
    Minerva Urol Nefrol; 2016 Feb; 68(1):49-57. PubMed ID: 26364570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrotoxicities.
    Goldstein SL
    F1000Res; 2017; 6():55. PubMed ID: 28163909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children.
    Goldstein SL; Dahale D; Kirkendall ES; Mottes T; Kaplan H; Muething S; Askenazi DJ; Henderson T; Dill L; Somers MJG; Kerr J; Gilarde J; Zaritsky J; Bica V; Brophy PD; Misurac J; Hackbarth R; Steinke J; Mooney J; Ogrin S; Chadha V; Warady B; Ogden R; Hoebing W; Symons J; Yonekawa K; Menon S; Abrams L; Sutherland S; Weng P; Zhang F; Walsh K
    Kidney Int; 2020 Mar; 97(3):580-588. PubMed ID: 31980139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of the NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) Program to Identify Nephrotoxicity in Pediatric Patients with Cystic Fibrosis.
    Newton ES; Kurzen EA; Linnemann RW; Shin HS
    J Pediatr Pharmacol Ther; 2021; 26(4):379-383. PubMed ID: 34035683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation Strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to Prevent Neonatal Medication-Induced Kidney Injury.
    Stone SB; Bisaccia E; Zakhary MS; Bashqoy F; Wagner D; Stoops C
    J Pediatr Pharmacol Ther; 2023; 28(4):287-296. PubMed ID: 37795277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children.
    Goswami E; Ogden RK; Bennett WE; Goldstein SL; Hackbarth R; Somers MJG; Yonekawa K; Misurac J
    Am J Health Syst Pharm; 2019 Oct; 76(22):1869-1874. PubMed ID: 31665764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis.
    Downes KJ; Dong M; Fukuda T; Clancy JP; Haffner C; Bennett MR; Vinks AA; Goldstein SL
    J Antimicrob Chemother; 2017 Jan; 72(1):254-260. PubMed ID: 27585963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.
    Goldstein SL; Mottes T; Simpson K; Barclay C; Muething S; Haslam DB; Kirkendall ES
    Kidney Int; 2016 Jul; 90(1):212-21. PubMed ID: 27217196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy".
    Camin RM; Cols M; Chevarria JL; Osuna RG; Carreras M; Lisbona JM; Coderch J
    Nefrologia; 2015; 35(2):197-206. PubMed ID: 26300514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.
    Hoste EA; Bagshaw SM; Bellomo R; Cely CM; Colman R; Cruz DN; Edipidis K; Forni LG; Gomersall CD; Govil D; Honoré PM; Joannes-Boyau O; Joannidis M; Korhonen AM; Lavrentieva A; Mehta RL; Palevsky P; Roessler E; Ronco C; Uchino S; Vazquez JA; Vidal Andrade E; Webb S; Kellum JA
    Intensive Care Med; 2015 Aug; 41(8):1411-23. PubMed ID: 26162677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of electronic surveillance tool for acute kidney injury: A retrospective analysis.
    Ahmed A; Vairavan S; Akhoundi A; Wilson G; Chiofolo C; Chbat N; Cartin-Ceba R; Li G; Kashani K
    J Crit Care; 2015 Oct; 30(5):988-93. PubMed ID: 26070247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotype standardization for drug-induced kidney disease.
    Mehta RL; Awdishu L; Davenport A; Murray PT; Macedo E; Cerda J; Chakaravarthi R; Holden AL; Goldstein SL
    Kidney Int; 2015 Aug; 88(2):226-34. PubMed ID: 25853333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions.
    Sutherland SM; Byrnes JJ; Kothari M; Longhurst CA; Dutta S; Garcia P; Goldstein SL
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):554-61. PubMed ID: 25649155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell- and biomarker-based assays for predicting nephrotoxicity.
    Huang JX; Blaskovich MA; Cooper MA
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1621-35. PubMed ID: 25382677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm.
    Kirkendall ES; Spires WL; Mottes TA; Schaffzin JK; Barclay C; Goldstein SL
    Appl Clin Inform; 2014; 5(2):313-33. PubMed ID: 25024752
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.